House Passes Bill Delay Gitmo Closure
House Passes Bill Delay Gitmo Closure
In a 244-174 vote, the House passed a bill to prevent the Obama Administration’s plan to transfer any more detainees from Guantanamo Bay, Cuba, until Congress passes its defense appropriations bill.
The bill, spearheaded by Indiana Republican Rep. Jackie Walorski, blocks any funding for transfer or release of detainees from the prison.
Republicans and the president have long been at odds on the Gitmo’s closure, with GOP lawmakers noting a recent report by the Office of the Director of National Intelligence found a third of those released return to terrorism.
“The news that two more former Guantanamo detainees have returned to the fight underscores the need for this action. The administration should heed the will of the House and cease its planned transfers of more terrorists back to their host countries,” House Speaker Paul Ryan said in a statement. “For the president, this is about keeping a campaign promise. For us, this is about keeping Americans safe.”
Sixty-one detainees remain at the facility, but 20 have been cleared for transfer this year. Vice President Joe Biden said in August he expect the facility to close by the time Obama leaves office.
The bill is unlikely to pass the Senate and the White House has threatened to veto the measure.
Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Anticipating Lifeway Foods’ Q3 Results Dust off your calendars and mark November 12, 2026—because that's when Lifeway Foods is putting its cards on the table for the third quarter. Nothing like a results call to see if your investments are eating right. NASDAQ:LWAY is no stranger to making some noise in the dairy aisle, thanks to their kefir—that fermented probiotic...
Continue Reading
LifeStance Health's Treatment Innovations Today, the spotlight is on LifeStance Health, as they're making waves with their treatment approaches for those battling stubborn, treatment-resistant depression. This isn't your run-of-the-mill attempt at tackling the beast—that familiar indifference masked as hope. No, this time around, they’re swinging with Esketamine and...
Continue Reading
A Fresh Start for Peapack-Gladstone's Corporate Relic Dust off the pages of history—Peapack-Gladstone's old Pfizer/Beneficial Finance campus is getting a makeover, and boy, it’s not your run-of-the-mill renovation. We're talking adaptive reuse to the tune of nearly $200 million, morphing this architectural gem into CopperWood Senior Living. With all the office...
Continue Reading
Navigating the Reddit Marketing Labyrinth Life ain't a walk in the park for marketers these days, especially in the tech and SaaS arenas. Some folks seem to have cracked the code—or at least one part of it. Enter Nicely Network, which has just snagged the crown as the Best Reddit Marketing Agency for B2B SaaS & Software Companies, thanks to its knack for connecting...
Continue Reading
Diverse Institutions Converge on AI Literacy A university conference isn't exactly where you'd expect seismic shifts, but this one's a bit of a dark horse. When big names like University of Phoenix, Boise State, Johns Hopkins, and the Medical University of South Carolina start syncing up their AI strategies, it feels like the sector's quietly brewing something big. At the...
Continue Reading
Hanwha and Chainlink: A Game Changer in Tokenization What do Hanwha Investment & Securities, a heavyweight in Korea's finance scene, and Chainlink, the wizard of onchain finance, think they're up to? They're buddies now, locked and loaded, to tokenize real-world assets (RWAs). They're not just shaking hands; they're aiming to jiggle the global finance bedrock....
Continue Reading
Cutting-Edge Unveiling at All in Print China 2026 In the bustling expo halls of the Shanghai New International Expo Centre, Ruizhi Machinery rolled out the red carpet for its latest inventions, stealing the limelight at the All in Print China 2026. Now, these were not your run-of-the-mill paper bag makers; we're talking about a set of machines that could redefine the gig...
Continue Reading
When the Trust Breaks October 29, 2026 was a gut punch for Xerox investors. Watching the outlook dive by $130 million, the coffee-feeling in the trading rooms turned into something more bitter. A $105 million boost they once celebrated from tariff receivables now seems to be a fleeting shadow, as Xerox itself scuttles its adjusted operating income for 2026 to a range of...
Continue Reading
From Small Fish to Big Discoveries: Meet Danionella cerebrum Who would've thought a diminutive fish with a see-through body would give a jolt to the study of vertebrate genomes? Thanks to Danionella cerebrum, researchers at the Whitehead Institute have created the very first complete whole-body single-cell atlas of an adult vertebrate. Forget the Wall Street clamor for a...
Continue Reading
Bumper Profits and Bold Moves for Instacart Here's a twist in the grocery tech aisle—Instacart's got some hefty numbers rolling in for Q3 and a whopper of an acquisition announcement. What seemed like just another Tuesday in the market is shaken by Instacart's reveal of their third-quarter financial results, showcasing a significant year-over-year climb that would make...
Continue Reading
Top 5 Most Recently Viewed Articles
Passenger Trends: A Bit of a Mixed Bag Traffic numbers can sometimes tell the real story, and for ASUR, it’s like reading a novel with plot twists. Colombia’s passenger traffic jumped 5.7%, fueled by robust international and domestic movements. Meanwhile, back in Puerto Rico? Things were not as rosy with a 3.1% drop due to lackluster domestic traffic. Mexico showed a...
Continue Reading
CVS Health Faces Challenges While Analysts Stay Positive Shares of CVS Health Corp (NYSE: CVS) have recently experienced a decline following the company’s preannouncement of a substantial earnings miss for the third quarter. This news comes during an exciting earnings season, generating considerable discussion among analysts and investors alike. Analyst Insights on CVS...
Continue Reading
Understanding Intercontinental Exchange Inc's Market Position Intercontinental Exchange Inc (NYSE: ICE) has recently experienced a notable increase in short interest, which has risen by 8.59% since the last report. Currently, there are approximately 7.83 million shares that have been sold short, representing 1.39% of the total shares available for trading. Based on recent...
Continue Reading
Jason Passwaters Receives Honorable Recognition Jason Passwaters, the dynamic CEO of Intel 471, has recently been celebrated for his significant contributions to the business world. His inclusion in the renowned Dallas 500 list acknowledges him as a pivotal figure among influential business leaders in the area. Passwaters’ Journey to Success With a strong foundation in...
Continue Reading
Investigation into Corporate Actions of Greenwich LifeSciences Greenwich LifeSciences, Inc. (NASDAQ: GLSI) finds itself under scrutiny as Purcell & Lefkowitz LLP initiates an investigation concerning potential breaches of fiduciary duties by the company’s directors. This investigation aims to address recent corporate actions that may not have aligned with the best...
Continue Reading